Desmoid tumor laboratory tests: Difference between revisions
Jump to navigation
Jump to search
Sara Mohsin (talk | contribs) |
Sara Mohsin (talk | contribs) |
||
Line 39: | Line 39: | ||
|- | |- | ||
|'''Immunohistochemistry''' | |'''Immunohistochemistry''' | ||
(aids histologic diagnosis) | (aids histologic diagnosis)<ref name="pmid17711447">{{cite journal| author=Carlson JW, Fletcher CD| title=Immunohistochemistry for beta-catenin in the differential diagnosis of spindle cell lesions: analysis of a series and review of the literature. | journal=Histopathology | year= 2007 | volume= 51 | issue= 4 | pages= 509-14 | pmid=17711447 | doi=10.1111/j.1365-2559.2007.02794.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17711447 }} </ref> | ||
|Spindle cells on immunohistochemical stains show the following features: | |Spindle cells on immunohistochemical stains show the following features: | ||
*Positive for: | *Positive for: |
Revision as of 18:37, 5 March 2019
Desmoid tumor Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2]
Overview
Immunohistochemical staining of spindle cells of desmoid tumors are positive for nuclear beta-catenin, vimentin, alpha smooth muscle actin, muscle actin and negative for desmin, cytokeratins, and S-100. Antibodies like smooth muscle actin, desmin and KIT may be helpful in distinguishing desmoid tumors from other tumors. In addition, APC germline mutations may be performed in patients with sporadic desmoid tumors with no clinical or famililal signs of FAP but having a family history of colorectal carcinoma in at least one family member.
Laboratory tests
- The molecular testing can be performed in general by performing a variety of following methods:
- In situ hybridization technique, such as fluorescence in situ hybridization (FISH)
- Immunohistochemistry (IHC)
- Next-generation sequencing (NGS)
- Polymerase chain reaction (PCR)
- Comparative genomic hybridization (CGH)
- Karyotyping including spectral karyotyping
- mRNA analysis
- Tissue microarrays (TMAs)
- Southern blot test
- Northern blot test
- Western blot test
- Eastern blot test
Clinical indications for performing molecular testing
- Molecular testing for Desmoid Tumor is done in order to:
- Assist (and in some cases, confirm) the initial diagnosis of desmoid tumor
- Distinguish other tumors/conditions that have similar histological features, when examined by a pathologist under the microscope
- Help in determining treatment options
- Confirm recurrence of the tumor: Tumor recurrence can either be at the original tumor site, or at a distant location (away from the initial site)
Significance of Molecular Testing
- Molecular testing in desmoid tumor has following significance:
- Presence of a positive test result helps aid, and in some cases, confirm the diagnosis of desmoid tumor
- Result can help to exclude other tumors having similar histological features
- It can help in determining the prognosis of the patient
- Test results may help in making treatment decisions in some cases
Other diagnostic tests | Associated characteristics features |
---|---|
Immunohistochemistry
(aids histologic diagnosis)[1] |
Spindle cells on immunohistochemical stains show the following features:
|
Antibodies | In order to distinguish desmoid tumors from other tumors, following antibodies are often examined:
|
APC germline mutational analysis |
|
Reference
- ↑ Carlson JW, Fletcher CD (2007). "Immunohistochemistry for beta-catenin in the differential diagnosis of spindle cell lesions: analysis of a series and review of the literature". Histopathology. 51 (4): 509–14. doi:10.1111/j.1365-2559.2007.02794.x. PMID 17711447.